Call Today For a Free Consultation Call For a Free Consultation (212) 732-9000
New York Personal Injury Attorneys Click for free consultation

Reports Have Surfaced That Bayer CEO Will Propose A Settlement of Nearly $8 Billion to End Roundup Litigation

September 6, 2019 in

As a response to the increasing number of lawsuits concerning Roundup weedkiller and its primary ingredient, glyphosate, discussion is intensifying regarding a likely settlement. Here, the consumer product liability attorneys at Sullivan Papain Block McGrath & Cannavo P.C. discuss recent updates regarding the Roundup litigation and what it could mean for individuals harmed by the popular herbicide.

Bayer’s Roundup Has Been the Subject of Substantial Controversy in Recent Years

Since Bayer’s $63 billion purchase of Monsanto in 2016, litigation surrounding the potential dangers of Roundup weedkiller has escalated significantly. The controversy over the safety of Roundup began in 2015 when the International Agency for Research on Cancer (IARC) released a report that connected glyphosate to cancer. In recent months, Bayer has lost major Roundup cases including a federal trial in which plaintiff Edwin Hardeman awarded $80 million by a jury who determined that his long-term exposure to Roundup weedkiller caused non-Hodgkin’s lymphoma. In addition, California couple Alva and Alberta Pilliod were awarded $2 billion in compensatory and punitive damages after a jury determined that Roundup had contributed to the development of their non-Hodgkin’s lymphoma—their payout was eventually reduced to $87 million, and these cases are both being appealed.

Bayer has been the subject of growing litigation as a result of consumer claims that long-term exposure to Roundup causes cancer and other serious illnesses. The number of lawsuits pending against Bayer regarding Roundup has risen to 18,400 and continues to grow, which has lead to Bayer’s CEO, Werner Baumann, considering a settlement to halt the rising litigation against the company.

Bayer’s Stock Has Steadily Dropped Since the Verdicts

Bayer’s stock has taken a substantial hit as a result of the growing controversy surrounding Roundup weedkiller. Specifically, Bayer’s shares have dropped approximately 40% in the last year as a result of claims that glyphosate may cause cancer.  The significant drop is likely a factor contributing to Baumann’s proposal to settle the lawsuits.

Bayer’s CEO Has Proposed to Settle Litigation Over Roundup Weedkiller

In order to settle all allegations regarding Roundup weedkiller and its primary ingredient, glyphosate, it has recently been reported that Baumann has proposed a “financially reasonable” settlement. While the settlement proposed by Baumann may potentially equal $8 billion, several have predicted that Bayer could ultimately settle for a much greater sum.

Discuss Your Options with the Team of Product Liability Attorneys at SPBMC Today

The settlement proposal by Bayer CEO Werner Baumann signifies that litigation surrounding the Roundup cancer claims could end, with plaintiffs potentially obtaining a substantial award as a result. The dedicated team of attorneys at Sullivan Papain Block McGrath & Cannavo P.C. are experienced in consumer product liability litigation and can provide you counsel in light of these recent updates. If you or a loved one has developed non-Hodgkin’s lymphoma after prolonged use of Roundup weedkiller, contact the attorneys at Sullivan Papain Block McGrath & Cannavo now.